Recs

1

Hurricane Sandy Hits Health Care Earnings

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

With markets closed today and Hurricane Sandy ravaging the Eastern Seaboard, investors looking forward to earnings reports from Pfizer (NYSE: PFE  ) , Vertex Pharmaceuticals (Nasdaq: VRTX  ) , Dendreon (Nasdaq: DNDN  ) , and Acorda Therapeutics (Nasdaq: ACOR  ) will have to wait a little longer for their quarterly dose of financial metrics. Pfizer and Vertex have moved their release dates from Monday to Thursday. Accorda and Dendreon have delayed their previously scheduled Tuesday releases to Wednesday and Friday, respectively.

Still, there's no shortage of companies scheduled to release results in spite of the weather. While it remains likely that more delays will be announced, at the time of this writing, nine companies are scheduled to report today and 25 are scheduled for tomorrow.

Below is a list of scheduled health care industry earnings releases, according to Thomson Reuters StreetEvents.

Monday, Oct. 29: 
ARRY, CHE, KND, LIFE, LMNX, OMI, FVE, HAE, MNKD.

Tuesday, Oct. 30:
ASTX, CERS, CRL, CSII, CYH, DVA, EPOC, GERN, MASI, MDAS, ONXX, PRXL, THRX, UAM, UHS, AGN, AVEO, CAH, CRVL, IPXL, MDSO, SPNC, CTIC, EXAC, EXAS.

More Expert Advice from The Motley Fool
The Motley Fool's chief investment officer has selected his No. 1 stock for the next year. Find out which stock in our brand-new free report: "The Motley Fool's Top Stock for 2013." I invite you to take a copy, free for a limited time. Just click here to access the report and find out the name of this under-the-radar company.

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Brenton Flynn owns no shares of the companies mentioned. The Motley Fool owns shares of Dendreon and Masimo. Motley Fool newsletter services have recommended buying shares of Vertex Pharmaceuticals. The Motley Fool has a disclosure policy.
We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 2082405, ~/Articles/ArticleHandler.aspx, 5/20/2013 7:46:48 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 days ago Sponsored by:
DOW 15,354.40 121.18 0.80%
S&P 500 1,667.47 17.00 1.03%
NASD 3,498.97 33.73 0.97%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/17/2013 4:00 PM
PFE $28.96 Down -0.29 -0.99%
Pfizer CAPS Rating: ****
VRTX $79.49 Up +1.60 +2.05%
Vertex Pharmaceuti… CAPS Rating: ***
ACOR $32.94 Up +0.41 +1.26%
Acorda Therapeutic… CAPS Rating: **
DNDN $4.01 Up +0.04 +1.01%
Dendreon Corp CAPS Rating: **

Advertisement